What are the main functions and therapeutic effects of Carpisetin/Tunicote?

As an AKT pathway inhibitor, Capivasertib's main function is to block the PI3K/AKT/mTOR signaling pathway. This pathway is abnormally activated in a variety of tumors, leading to tumor cell proliferation, survival, and drug resistance. By inhibiting AKT, carpiseti can promote tumor cell apoptosis, inhibit proliferation, and enhance the efficacy of other therapeutic drugs, thereby achieving precise intervention in tumors.

In the treatment of breast cancerand othersolid tumors related to PI3K/AKT activation, capisetide has shown clear clinical efficacy. It can extend progression-free survival, improve quality of life, and provide new treatment options in patients who have failed multiple lines of therapy. Overseas clinical studies have shown that carpisetin is particularly effective in breast cancer patients who activate the AKT pathway. It can delay disease progression and reduce the occurrence of chemotherapy-related side effects.

Carpisetin also has good oral administration convenience, allowing patients to be treated under outpatient conditions, reducing the number of hospitalizations and improving treatment compliance. During treatment, hematological and biochemical indicators need to be monitored regularly, adverse reactions such as hyperglycemia, rash or gastrointestinal symptoms should be observed, and the dose should be adjusted according to patient tolerance. Combined with genetic testing and personalized plan design, carpiseti can achieve targeted and precise treatment and provide patients with personalized anti-cancer management strategies.

In short, carpisetin blocks key tumor growth mechanisms by targeting theAKT signaling pathway, providing effective treatment options for patients with breast cancer and other related tumors. Its main therapeutic effects are reflected in delaying disease progression, improving quality of life, enhancing the efficacy of other therapies, and providing a new option after the failure of multiple lines of treatment. Scientific and standardized medication and follow-up management are the key to achieving long-term benefits and reducing the risk of side effects.

Reference materials:https://www.drugs.com/mtm/capivasertib.html